Ad is loading...
MENU

GALT Galectin Therapeutics Forecast, Technical & Fundamental Analysis

a developer of drugs to combat various diseases

Industry Biotechnology
GALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
GALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GALT is expected to report earnings to rise 16.67% to -20 cents per share on March 27

Galectin Therapeutics GALT Stock Earnings Reports
Q4'24
Est.
$-0.21
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.04
Q1'24
Missed
by $0.03
Q4'23
Missed
by $0.06
The last earnings report on November 14 showed earnings per share of -18 cents, beating the estimate of -20 cents. With 219.07K shares outstanding, the current market capitalization sits at 172.51M.
A.I. Advisor
published General Information

General Information

a developer of drugs to combat various diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
14
Web
https://www.galectintherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLESX15.350.12
+0.79%
GS Energy Infrastructure Fd R6 Shares
CCMMX10.02N/A
N/A
Conestoga Mid Cap Investors
MFWHX17.83-0.05
-0.28%
MFS Global Total Return R3
BOGIX33.09-0.39
-1.16%
SGI Small Cap Core Fund I Shares
PCAOX83.49-1.20
-1.42%
Principal Capital Appreciation R3

GALT and Stocks

Correlation & Price change

A.I.dvisor tells us that GALT and SNPX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GALT and SNPX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GALT
1D Price
Change %
GALT100%
+0.73%
SNPX - GALT
32%
Poorly correlated
-8.05%
RNAC - GALT
32%
Poorly correlated
+1.82%
CDXC - GALT
27%
Poorly correlated
-5.28%
RNAZ - GALT
27%
Poorly correlated
-2.92%
ERAS - GALT
26%
Poorly correlated
-4.98%
More